Safety, Tolerability and Immunogenicity of Two Different Formulations of MenB Vaccine, When Administered to Healthy Infants - Related Studies

Safety, Tolerability and Immunogenicity of Two Different Formulations of MenB Vaccine, When Administered to Healthy Infants

This study is ongoing, but not recruiting participants.

Study NCT00433914. Last updated on August 28, 2007. Information provided by Novartis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Meningococcal Disease

2	Additional conditions recognized in this trial
		Meningococcal Infections

3	More general conditions related to this trial
		Bacterial Infections
		Gram-Negative Bacterial Infections
		Neisseriaceae Infections

4	Interventions listed in this trial
		Serogroup B meningococcal Vaccine

5	Sponsors listed in this trial
		Novartis
		Novartis Vaccines